Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 9 results.
User Information
Export Records
  1. 1.   SHP2 clinical phenotype, cancer, or RASopathies, can be predicted by mutant conformational propensities
  2. Liu,Yonglan; Zhang,Wengang; Jang,Hyunbum; Nussinov,Ruth
  3. Cellular and Molecular Life Sciences : CMLS. 2023, Dec 12; 81(1): 5.
  1. 2.   HNO Protects the Myocardium against Reperfusion Injury, Inhibiting the mPTP Opening via PKCe Activation
  2. Mancardi, Daniele; Pagliaro, Pasquale; Ridnour,Lisa; Tocchetti, Carlo G; Miranda, Katrina; Juhaszova, Magdalena; Sollott, Steven J; Wink,David; Paolocci, Nazareno
  3. Antioxidants (Basel, Switzerland). 2022, Feb 14; 11(2):
  1. 3.   High-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design
  2. Lountos, George; Raran-Kurussi, Sreejith; Zhao, Bryan M; Dyas, Beverly K; Burke, Terrence; Ulrich, Robert G; Waugh, David
  3. Acta crystallographica. Section D, Structural biology. 2018, Oct 01; 74(Pt 10): 1015-1026.
  1. 4.   The protein tyrosine phosphatase receptor type R gene is an early and frequent target of silencing in human colorectal tumorigenesis
  2. Menigatti, M.; Cattaneo, E.; Sabates-Bellver, J.; Ilinsky, V. V.; Went, P.; Buffoli, F.; Marquez, V. E.; Jiricny, J.; Marra, G.
  3. Molecular Cancer. 2009, Dec; 8: 11.
  1. 5.   A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins
  2. Townsend, D. M.; Findlay, V. J.; Fazilev, F.; Ogle, M.; Fraser, J.; Saavedra, J. E.; Ji, X. H.; Keefer, L. K.; Tew, K. D.
  3. Molecular Pharmacology. 2006, FEB; 69(2): 501-508.
  1. 6.   Enantioselective synthesis of (S)-3-carboxy-4-((carboxy)difluoromethyl)phenylalanine in protected form and its incorporation into a PTP-1B-directed tripeptide
  2. Kang, S. U.; Yang, G.; Li, W.; Zhang, Z. Y.; Burke, T. R.
  3. Chemistry & Biodiversity. 2004 1(4): 626-633.
  1. 7.   CD45 protein-tyrosine phosphatase inhibitor development
  2. Lee, K.; Burke, T. R.
  3. Current Topics in Medicinal Chemistry. 2003 3(7): 797-807.
  1. 8.   The ever-expanding Ly49 gene family: repertoire and signaling
  2. Anderson, S. K.; Ortaldo, J. R.; McVicar, D. W.
  3. Immunological Reviews. 2001 181: 79-89.
  1. 9.   Evidence For Generation of Oxidative Stress in Brain By Mptp - in Vitro and in Vivo Studies in Mice
  2. Sriram, K.; Pai, K. S.; Boyd, M. R.; Ravindranath, V.
  3. Brain Research. 1997 749(1): 44-52.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel